Hundreds Seek To Centralize NJ Taxotere Hair Loss Suits

By Bill Wichert (April 18, 2018, 9:31 PM EDT) -- Hundreds of women have called for centralized management of their New Jersey state actions alleging Sanofi-Aventis and other drug companies failed to adequately warn consumers about the risk of permanent hair loss from using the breast cancer drug Taxotere....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!